Sarah K. Moore

Sarah K. Moore

Auto-generated profile, based on publicly available information

Sarah K. Moore

Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in International Journal of Drug Policy
Verified
Journal Article
Closed access
SBSarah Bessen
Sarah Bessen
SMStephen A. Metcalf
Stephen A. Metcalf
ESElizabeth C. Saunders
Elizabeth C. Saunders
SMSarah K. Moore
Sarah K. Moore
AMAndrea Meier
Andrea Meier
LMLisa A. Marsch
Lisa A. Marsch

19 July 2019 in JMIR Formative Research
Verified
Journal Article
Open access
SMSarah K Moore
Sarah K Moore
MGMichael Grabinski
Michael Grabinski
SBSarah Bessen
Sarah Bessen
JBJacob T Borodovsky
Jacob T Borodovsky
LMLisa A Marsch
Lisa A Marsch
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Background: The unprecedented number of youth engaged in nonmedical use of prescription opioids (PO), as well as the myriad negative consequences of such misuse emphasize the importance of prevention efforts targeting this public health crisis. Although there are several science-based, interactive, drug-abuse prevention programs focused on preventing use of non-prescription drugs in youth, to our knowledge, there are no science-based, interactive programs focused on the prevention of prescription opioid abuse among adolescents. Objective: Objectives: The aim of this study was to develop and conduct a formative evaluation of a science-based, interactive web-based program focused on the prevention of prescription opioid abuse among adolescents aged 12-17 (Pop4Teens.c4tbh.org). This work was conducted to prepare for a randomized, controlled trial designed to evaluate the effectiveness of Pop4Teens compared to an active control website, JustThinkTwice.com (Drug Enforcement Administration) in impacting knowledge and attitudes about prescription opioids, perceptions of risk associated with abuse of prescription opioids, as well as intentions to use and actual use of prescription opioids. Methods: Methods: We conducted six focus groups with 30 youth (M = 5/group: 12-19 years of age eligible) along a continuum of exposure to POs (in treatment for opioid use disorder, in general treatment for other substance use disorder, prescribed an opioid, and opioid naïve), and writing sessions with 30 youth in treatment for opioid use disorder (12-19) to inform the development of the web-based prevention tool. Feasibility and acceptability of a prototype of the web-based intervention were then assessed through individual feedback sessions with 57 youth (drawn from same populations as focus groups). Results: Results: We successfully completed the development of a web-based prescription opioid abuse prevention program (Pop4Teens). Analyses of focus group transcripts informed the development of the program (e.g., quiz content/format, script writing, story editing). Selected writing session narratives anchored the planned scientific content by lending credibility, as well as informing the development of compelling storylines intended to motivate youth to engage with the program. Feedback session data indicate that the web-based tool could be potentially useful and acceptable. Also, feedback session participants demonstrated significant increases in their knowledge of key topics related to the prevention of prescription opioid abuse after exposure to sections of the web-based program. Conclusions: Conclusions: The opioid crisis is predicted to get worse before it gets better. An effective response will likely require a multi-pronged strategy inclusive of effective evidence-based prevention programs acceptable to, and accessible by, a majority of youth. Clinical Trial: NA

25 February 2021 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
LMLisa A Marsch
Lisa A Marsch
SMSarah K Moore
Sarah K Moore
MGMichael Grabinski
Michael Grabinski
SBSarah Y Bessen
Sarah Y Bessen
JBJacob Borodovsky
Jacob Borodovsky
ESEmily Scherer
Emily Scherer
Background: Prescription opioid (PO) use is common among adolescents in the United States. Despite recent declines from unprecedented peaks in adolescent PO use (eg, in 2012-2013), there is seemingly paradoxical evidence that PO-related consequences (eg, opioid use disorder and overdoses) are increasing. These trends and their possible consequences emphasize the importance of prevention efforts targeting PO misuse. To our knowledge, we have developed the first interactive web-based program (POP4Teens [P4T]) focused specifically on the prevention of PO misuse among adolescents. Objective: This study aimed to evaluate the effectiveness of P4T, a web-based program designed to prevent adolescent PO misuse, in comparison with JustThinkTwice (JTT), an active control website, on PO-related attitudes, knowledge, risk perception, and intentions to use. Methods: We conducted a web-based randomized controlled trial in 2018. A total of 406 adolescents (aged 12-17 years) were randomly assigned to either P4T or JTT. The outcome variables were attitudes, knowledge, and risk perceptions associated with PO misuse, intentions to use POs, and program feedback. Data were collected at baseline and at 1, 3, and 6 months. Results: Both programs resulted in significant and sustained improvements in intention to use POs, increased perceived risk, impacted expectancies consistent with prevention, and improved PO refusal skills. P4T produced significantly greater increases in PO-related knowledge than JTT did, and it was reportedly easier to use and more liked. Baseline scores for youth reporting past-year medical use of POs, friends who engage in nonmedical use of POs, and/or poor mental health underscored their at-risk status compared with youth from the other groups. Conclusions: P4T positively impacted all study variables that are known to prevent PO misuse among teens. Moreover, its web-based nature simplifies the dissemination and implementation of this novel tool designed to help meet the challenges of the evolving national opioid crisis. Trial Registration: ClinicalTrials.gov NCT02737696; https://clinicaltrials.gov/ct2/show/NCT02737696

1 November 2021 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
TFThomas Fatkin
Thomas Fatkin
SMSarah K. Moore
Sarah K. Moore
KOKayley Okst
Kayley Okst
TCTimothy B Creedon
Timothy B Creedon
FSFarah Samawi
Farah Samawi
ZSZev Schuman-Olivier
Zev Schuman-Olivier

2 December 2020 in Substance Abuse
Verified
Journal Article
Closed access
SMSarah K. Moore
Sarah K. Moore
ESElizabeth C. Saunders
Elizabeth C. Saunders
EHEmily Hichborn
Emily Hichborn
BMBethany McLeman
Bethany McLeman
AMAndrea Meier
Andrea Meier
JMJennifer McNeely
Jennifer McNeely
Background: Few primary care patients are screened for substance use. As part of a phased feasibility study examining the implementation of electronic health record-integrated screening with the Tobacco, Alcohol, and Prescription Medication Screening (TAPS) Tool and clinical decision support (CDS) in rural primary care clinics, focus groups were conducted to identify early indicators of success and challenges to screening implementation. Method: Focus groups ( n = 6) were conducted with medical assistants (MAs: n = 3: 19 participants) and primary care providers (PCPs: n = 3: 13 participants) approximately one month following screening implementation in three Federally Qualified Health Centers in Maine. Rapid analysis and matrix analysis using Proctor's Taxonomy of Implementation Outcomes were used to explore implementation outcomes. Results: There was consensus that screening is being used, but use of the CDS was lower, in part due to limited positive screens. Fidelity was high among MAs, though discomfort with the CDS surfaced among PCPs, impacting adoption and fidelity. The TAPS Tool's content, credibility and ease of workflow integration were favorably assessed. Challenges include screening solely at annual visits and self-administered screening for certain patients. Conclusions: Results reveal indicators of implementation success and strategies to address challenges to screening for substance use in primary care.

2 June 2022 in Frontiers in Psychology
Verified
Journal Article
Open access
SMSarah K. Moore
Sarah K. Moore
KOKayley Okst
Kayley Okst
LSLydia Smith
Lydia Smith
TFThomas Fatkin
Thomas Fatkin
TCTimothy Creedon
Timothy Creedon
ZSZev Schuman-Olivier
Zev Schuman-Olivier
Background: Opioid-related deaths continue to rise. Psychological trauma is commonly comorbid with Opioid Use Disorder (OUD). Adverse childhood experiences can disrupt the development of emotion regulation, increasing risk of substance use. Self-compassion may reduce OUD risk and outcomes by facilitating emotion regulation, decreasing the toxicity of shame, and reducing internalized stigma that can hinder recovery. Mindfulness practice enhances self-compassion.Methods: This study is part of a pilot (N = 18) of the Mindful Recovery OUD Care Continuum (M-ROCC) during buprenorphine office-based opioid treatment (OBOT). The present study was conducted to gain a deeper understanding of the intervention’s effects on self-compassion development, and to explore differential changes in self-compassion during the intervention among participants with varying intensity of trauma exposure measured by high levels of childhood adversity (defined by 4+ adverse childhood experiences (ACEs) at baseline). We conducted secondary analyses of a subset of qualitative interview data (N = 11 unique participants) collected for the pilot study (weeks 4 and 24, 14 total interviews) to elaborate upon changes in Self-Compassion Scale (SCS-SF) scores.Results: In the primary pilot study, participants’ mean SCS-SF scores shifted significantly from baseline to week 24, β = 0.22, p = 0.028. This change is elaborated upon through interviews. Despite pervasive challenges to becoming more self-compassionate (e.g., trauma histories and substance use), participants reported increased compassionate self-responding and decreased uncompassionate self-responding. Mindfulness training was identified as the primary mechanism underlying the shift. Kindness to self and others and—to a lesser extent an increased sense of common humanity—were also identified as key to overall self-compassion. Compared to those in the lower ACEs group, participants in the higher ACEs group tended to have lower baseline self-compassion scores (d = 1.09, p = 0.055).Conclusion: M-ROCC may increase self-compassion among patients with OUD during OBOT by increasing compassionate, and decreasing uncompassionate, self-responding. Patients with OUD with greater childhood adversity tended to have lower levels of self-compassion, which improved with M-ROCC. Future trials with larger samples are needed to confirm these potential outcomes, mechanisms, and differential impacts between ACEs subgroups.